Related Experiment Video
Updated: Aug 8, 2026

Revealing the Ferroptotic Phenotype of Medulloblastoma
Published on: March 15, 2024
Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cells
O Pasder1, S Shpungin, Y Salem
1The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.
Abstract:
Fer is a nuclear and cytoplasmic intracellular tyrosine kinase. Herein we show that Fer is required for cell-cycle progression in malignant cells. Decreasing the level of Fer using the RNA interference (RNAi) approach impeded the proliferation of prostate and breast carcinoma cells and led to their arrest at the G0/G1 phase. At the molecular level, knockdown of Fer resulted in the activation of the retinoblastoma protein (pRB), and this was reflected by profound hypo-phosphorylation of pRB on both cyclin-dependent kinase CDK4 and CDK2 phosphorylation sites. Dephosphorylation of pRB was not seen upon the direct targeting of either CDK4 or CDK2 expression, and was only partially achieved by the simultaneous depletion of these two kinases. Amino-acid sequence analysis revealed two protein phosphatase 1 (PP1) binding motifs in the kinase domain of Fer and the association of Fer with the pRB phosphatase PP1alpha was verified using co-immunoprecipitation analysis. Downregulation of Fer potentiated the activation of PP1alpha and overexpression of Fer decreased the enzymatic activity of that phosphatase. Our findings portray Fer as a regulator of cell-cycle progression in malignant cells and as a potential target for cancer intervention.
Insights
Fer, a tyrosine kinase, is crucial for malignant cell-cycle progression. Inhibiting Fer halts cancer cell proliferation by activating the retinoblastoma protein (pRB), offering a potential cancer intervention target.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Fer is an intracellular tyrosine kinase found in both the nucleus and cytoplasm.
- Cell-cycle progression is a fundamental process often dysregulated in malignant cells.
Purpose of the Study:
- To investigate the role of Fer in cell-cycle progression in cancer cells.
- To elucidate the molecular mechanisms by which Fer influences cell-cycle regulation.
- To evaluate Fer as a potential therapeutic target for cancer intervention.
Main Methods:
- RNA interference (RNAi) was used to decrease Fer levels in prostate and breast carcinoma cells.
- Western blotting and co-immunoprecipitation were employed to analyze protein levels, phosphorylation states, and interactions.
- Amino-acid sequence analysis identified potential protein phosphatase 1 (PP1) binding motifs within Fer.
Main Results:
- Decreasing Fer levels via RNAi impeded cancer cell proliferation and caused G0/G1 phase arrest.
- Fer knockdown led to retinoblastoma protein (pRB) activation, evidenced by hypo-phosphorylation at CDK4 and CDK2 sites.
- Fer interacts with and regulates the activity of the pRB phosphatase PP1alpha, with Fer downregulation potentiating PP1alpha activity.
Conclusions:
- Fer is essential for cell-cycle progression in malignant cells.
- Fer regulates pRB dephosphorylation through its interaction with PP1alpha.
- Fer represents a promising molecular target for novel cancer therapies.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Inhibition of CDK Activity